These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3792606)

  • 21. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy.
    James PR; Hardman SM
    Heart; 1997 Jun; 77(6):583-4. PubMed ID: 9227310
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of right atrial and peripheral procainamide infusion levels in patients with spontaneous or induced atrial fibrillation.
    Lurie KG; Buscemi PJ; Iskos D; Adkisson W; Fahy GJ; Sakaguchi S; Hoff J; Benditt DG
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):277-83. PubMed ID: 9474688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Pill-in-the-pocket' treatment for recent-onset atrial fibrillation.
    Anusionwu O; Wali A
    Heart; 2010 Oct; 96(19):1605; author reply 1605-6. PubMed ID: 20702537
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles].
    Lévy RH
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415
    [No Abstract]   [Full Text] [Related]  

  • 25. [Early-onset acute toxic hepatitis induced by intravenous amiodarone administration].
    González Galilea A; García Sánchez MV; la Mata García M; Miño Fugarolas G
    Gastroenterol Hepatol; 2002; 25(6):392-4. PubMed ID: 12069701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 27. [The cardiotoxic properties of anti-arrhythmia agents].
    Spasov AA; Gurova NA
    Eksp Klin Farmakol; 1997; 60(2):20-3. PubMed ID: 9206561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current state and perspectives of pharmacological and non-pharmacological treatment of atrial fibrillation: overview].
    Okumura K
    Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):52-4. PubMed ID: 20154409
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous amiodarone for arrythmia management.
    Halkin A; Shibolet O
    Ann Intern Med; 1998 Mar; 128(6):505. PubMed ID: 9499340
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
    Piotrovskiĭ VK; Blagodatskikh SV; Metelitsa VI; Smirnov VK; Gorshkov VA
    Farmakol Toksikol; 1985; 48(4):83-6. PubMed ID: 2412887
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias.
    Naccarelli GV; Jalal S
    Circulation; 1995 Dec; 92(11):3154-5. PubMed ID: 7586296
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetics and dynamics of sematilide.
    Shi J; Lasser T; Koziol T; Hinderling PH
    Ther Drug Monit; 1995 Oct; 17(5):437-44. PubMed ID: 8585104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amrinone and amiodarone: serious confusion in the intravenous line.
    Pollak PT; Pierce S; Cooke C
    Arch Intern Med; 1998 Jan; 158(2):193-4. PubMed ID: 9448563
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction.
    Shiga T; Ando S; Suzuki T; Matsuda N; Kasanuki H
    J Electrocardiol; 2001 Jan; 34(1):77-80. PubMed ID: 11239376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment principles in acute myocardial infarct].
    Oganov RG
    Kardiologiia; 1980 Jan; 20(1):108-14. PubMed ID: 6101625
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of oral amiodarone as a chronic treatment in a patient with prior fulminant hepatitis due to intravenous amiodarone].
    López-Gómez D; Nicolás J; Frigola JM; Manito N; Esplugas E
    Rev Esp Cardiol; 1999 Mar; 52(3):201-3. PubMed ID: 10193175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Limitation of adrenergic cardiovascular damage by exogenous infusion of a regulatory peptide dalargin].
    Pashutin SB
    Kardiologiia; 1992 Mar; 32(3):56-8. PubMed ID: 1405215
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.